Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.35 USD | -0.74% | -3.95% | -71.39% |
Apr. 30 | Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating | MT |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 58.91M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -54M | EV / Sales 2024 * | - |
Net cash position 2024 * | 89.1M | Net cash position 2025 * | 37.7M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.94
x | P/E ratio 2025 * |
-2.14
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.41% |
1 day | -0.74% | ||
1 week | -3.95% | ||
Current month | -3.95% | ||
1 month | -51.80% | ||
3 months | -46.01% | ||
6 months | -7.92% | ||
Current year | -71.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 08-04-30 | |
Melissa Gaines
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cheng Fang
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Hoffman
CHM | Chairman | 73 | 13-12-31 |
Chief Executive Officer | 73 | 08-04-30 | |
Reid McCarthy
BRD | Director/Board Member | 70 | 21-04-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 5.35 | -0.74% | 329,247 |
24-05-06 | 5.39 | +4.05% | 399,600 |
24-05-03 | 5.18 | -4.95% | 609,601 |
24-05-02 | 5.45 | -10.80% | 673,458 |
24-05-01 | 6.11 | +9.69% | 1,078,130 |
Delayed Quote Nyse, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-71.39% | 58.91M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- ANVS Stock